published meta-analysis   sensitivity analysis   studies

Renin-angiotensin-system-acting agents in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsUniversity of Minnesota, 2020 1.29 [0.51; 3.26] 1.29[0.51; 3.26]University of Minnesota, 202010%205NAnot evaluable deathsdetailed resultsLopes (BRACE CORONA), 2021 0.97 [0.38; 2.50] Nouri-Vaskeh, 2021 0.35 [0.06; 1.91] University of Minnesota, 2020 0.68 [0.11; 4.16] 0.75[0.35; 1.59]Lopes (BRACE CORONA), 2021, Nouri-Vaskeh, 2021, University of Minnesota, 202030%944moderatenot evaluable hospital dischargedetailed resultsUniversity of Minnesota, 2020 0.64 [0.37; 1.11] 0.64[0.37; 1.11]University of Minnesota, 202010%205NAnot evaluable hospitalizationdetailed resultsUniversity of Minnesota, 2020 1.63 [0.94; 2.85] 1.63[0.94; 2.85]University of Minnesota, 202010%205NAnot evaluable mechanical ventilationdetailed resultsLopes (BRACE CORONA), 2021 1.25 [0.76; 2.06] University of Minnesota, 2020 1.34 [0.66; 2.73] 1.28[0.85; 1.93]Lopes (BRACE CORONA), 2021, University of Minnesota, 202020%862moderatenot evaluable0.25.01.0relative treatment effectwww.metaEvidence.org2024-05-14 17:23 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 612,552,590,891,605,892,722,618,609 - roots T: 290